Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL785147 | 0.87 | — | — | |
| SCHEMBL1123 | 0.87 | — | — | |
| SCHEMBL338264 | 0.87 | KDM4E (0.34) | BRD4KDM4EGAAPOLB | |
| Succinic Acid SCHEMBL28778164 | 0.86 | LMNA (0.39) | KMT2AGAALMNA | |
| Alcohol SCHEMBL20856433 | 0.86 | ALDH1A1 (0.33) | BRD4KDM4ELMNA | |
| SCHEMBL25175816 | 0.84 | — | — | |
| SCHEMBL21409789 | 0.84 | — | — | |
| SCHEMBL21409686 | 0.84 | — | — | |
| SCHEMBL21409683 | 0.84 | — | — | |
| Ammonia Solution, Strong SCHEMBL1914672 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4400125-A1 | SOL-GEL TRANSITION OF 6-ARM PEG HYDROGEL OVER TIME | Sunbio Inc. (KR) | 2024-07-17 | — | — | EP | claimed |
| CN-117915964-A | Sol-gel conversion of 6-arm PEG hydrogels over time | 太阳生物公司 | 2024-04-19 | — | — | CN | claimed |
| CN-116273217-A | Surface-modified biochip substrate, biochip and application thereof | 深圳华大生命科学研究院 | 2023-06-23 | — | — | CN | claimed |
| WO-2023038463-A1 | SOL-GEL TRANSITION OF 6-ARM PEG HYDROGEL OVER TIME | 선바이오(주) | 2023-03-16 | — | — | WO | claimed |
| CN-115248308-A | Application of poly-levodopa nanoparticles in preparation of immunochromatography detection test strip | 浙江大学 | 2022-10-28 | — | — | CN | claimed |
| EP-3539570-B1 | PEGYLATED ENDOSTATIN ANALOGUE AND APPLICATION THEREOF | BEIJING PROTGEN LTD (CN) | 2022-04-13 | — | — | EP | claimed |
| CN-114099697-A | Immune microenvironment regulation nanoparticle with enhanced photoresponse penetration and preparation method thereof | 复旦大学 | 2022-03-01 | — | — | CN | claimed |
| US-20200270333-A1 | PEGYLATED ENDOSTATIN ANALOGUE AND APPLICATION THEREOF | BEIJING PROTGEN LTD. (CN) | 2020-08-27 | — | — | US | claimed |
| EP-3539570-A1 | PEGYLATED ENDOSTATIN ANALOGUE AND APPLICATION THEREOF | Beijing Protgen Ltd. (CN) | 2019-09-18 | — | — | EP | claimed |
| US-6410017-B1 | PERSONAL CARE WIPE COMPOSITION COMPRISING WATER INSOLUBLE SUBSTRATE, PLURALITY OF ACTIVE PROTEINS, AND BINDING MEANS, COMPRISING POLYMERIC TETHER, PERMANENTLY ATTACHING EACH ENZYME TO SUBSTRATE | THE PROCTER & GAMBLE COMPANY | 2002-06-25 | — | — | US | claimed |
| EP-1115366-A2 | PERSONAL CARE COMPOSITIONS CONTAINING ACTIVE PROTEINS TETHERED TO A WATER INSOLUBLE SUBSTRATE | The Procter & Gamble Company (US) | 2001-07-18 | — | — | EP | claimed |
| WO-2000016733-A2 | PERSONAL CARE COMPOSITIONS CONTAINING ACTIVE PROTEINS TETHERED TO A WATER INSOLUBLE SUBSTRATE | THE PROCTER & GAMBLE COMPANY (US) | 2000-03-30 | — | — | WO | claimed |
| EP-4400125-A1 | SOL-GEL TRANSITION OF 6-ARM PEG HYDROGEL OVER TIME | Sunbio Inc. (KR) | 2024-07-17 | — | — | EP | disclosed |
| CN-117915964-A | Sol-gel conversion of 6-arm PEG hydrogels over time | 太阳生物公司 | 2024-04-19 | — | — | CN | disclosed |
| WO-2023192203-A2 | NOVEL PLANT VIRUS AND BACTERIOPHAGE VACCINES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-05 | — | — | WO | disclosed |
| CN-116273217-A | Surface-modified biochip substrate, biochip and application thereof | 深圳华大生命科学研究院 | 2023-06-23 | — | — | CN | disclosed |
| US-20050267326-A1 | Percutaneous chemical sensor based on fluorescence resonant energy transfer (FRET) | ALFRED E. MANN INSTITUTE FOR BIOMEDICAL ENG. AT THE UNIVERSITY OF SOUTHERN CALIFORNIA | 2005-12-01 | — | — | US | disclosed |
| US-20050260651-A1 | Enhanced biologically active conjugates | OLDTECH, INC. | 2005-11-24 | — | — | US | disclosed |
| US-20050260153-A1 | Facilitation of iontophoresis using charged moieties | OLDTECH, INC. | 2005-11-24 | — | — | US | disclosed |
| WO-2005110489-A2 | NUCLEIC ACID APTAMERS CONJUGATED TO HIGH MOLECULAR WEIGHT STERIC GROUPS | (OSI) EYETECH, INC. (US) | 2005-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050260153-A1 | Facilitation of iontophoresis using charged moieties | ANXA11, SLC7A1, TRPC6 | BRD4 2805/4885KMT2A 2834/4885KDM4E 4536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.